These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2161108)

  • 1. The effect of the NMDA receptor antagonist, MK-801, on the course and outcome of kindling.
    Mintz M; Rose IC; Herberg LJ
    Pharmacol Biochem Behav; 1990 Apr; 35(4):815-21. PubMed ID: 2161108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models.
    McNamara JO; Russell RD; Rigsbee L; Bonhaus DW
    Neuropharmacology; 1988 Jun; 27(6):563-8. PubMed ID: 2843782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
    Herberg LJ; Rose IC
    Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
    Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic effects of MK-801, a noncompetitive NMDA-receptor antagonist, in the low-frequency kindling model of epilepsy.
    Minabe Y; Emori K; Shibata R; Kurachi M
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):755-61. PubMed ID: 1487858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of FG 7142 kindling by anticonvulsants acting at sites distant from the benzodiazepine receptor.
    Stephens DN; Weidmann R
    Brain Res; 1989 Jul; 492(1-2):89-98. PubMed ID: 2546658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats.
    Trommer BL; Pasternak JF
    Brain Res Dev Brain Res; 1990 May; 53(2):248-52. PubMed ID: 2162746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy.
    Rundfeldt C; Wlaź P; Löscher W
    Brain Res; 1994 Aug; 653(1-2):125-30. PubMed ID: 7982045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat.
    Gilbert ME; Mack CM
    Brain Res; 1990 Jun; 519(1-2):89-96. PubMed ID: 2204470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amygdala kindling does not alter the N-methyl-D-aspartate receptor-channel complex which modulates dopamine release in the rat striatum and amygdala.
    Ohmori T; Nakamura F; Koyama T; Yamashita I
    Brain Res; 1992 Aug; 587(2):257-62. PubMed ID: 1388086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat.
    Marrannes R; Willems R; De Prins E; Wauquier A
    Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NMDA receptor antagonist MK-801 has a dissociative effect on seizure activity of hippocampal-kindled cats.
    Wada Y; Hasegawa H; Nakamura M; Yamaguchi N
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1269-72. PubMed ID: 1475311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.